Renovacor
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Renovacor and buy or sell other stocks, ETFs, and their options commission-free!About RCOR
Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases.
CEOMagdalene K. Cook, MD
CEOMagdalene K. Cook, MD
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2013
Founded2013
Employees—
Employees—
RCOR Key Statistics
Market cap55.26M
Market cap55.26M
Price-Earnings ratio-4.18
Price-Earnings ratio-4.18
Dividend yield—
Dividend yield—
Average volume28.30K
Average volume28.30K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$9.74
52 Week high$9.74
52 Week low$1.34
52 Week low$1.34
Stock Snapshot
As of today, Renovacor(RCOR) shares are valued at $3.20. The company's market cap stands at 55.26M, with a P/E ratio of -4.18.
On 2025-12-13, Renovacor(RCOR) stock opened at —, reached a high of —, and a low of —.
The Renovacor(RCOR)'s current trading volume is 0, compared to an average daily volume of 28.3K.
During the past year, Renovacor(RCOR) stock moved between $1.34 at its lowest and $9.74 at its peak.
During the past year, Renovacor(RCOR) stock moved between $1.34 at its lowest and $9.74 at its peak.
People also own
Based on the portfolios of people who own RCOR. This list is generated using Robinhood data, and it’s not a recommendation.